N-acetylcysteine (NAC) nebulizer therapy is effective and safe as a short-term (12-week) treatment for reducing phlegm in chronic obstructive pulmonary disease (COPD), according to study findings ...

The move will enable the country’s more than 100 million chronic pulmonary disease patients to access free annual check-ups.

In addition to being diagnosed more frequently in older patients, pulmonary arterial hypertension (PAH) is more frequently ...

Pulmonary nodules smaller than two centimetres can be cured if detected early As part of European Lung Cancer Week, Dr Joseba ...

Around 15,000 Kiwis - a number of them Māori and Pasifika - living with chronic obstructive pulmonary disease (COPD), the ...

Verona Pharma's Ohtuvayre offers a novel dual mechanism of action for COPD at a premium price, presenting market potential ...

A research group from Ningbo Institute of Materials Technology and Engineering (NIMTE) of the Chinese Academy of Sciences ...

A flare-up in chronic obstructive pulmonary disease (COPD) can be predicted through changes in a person's voice, a new study ...

At the European Respiratory Society (ERS) congress in Vienna, Loes van Bemmel of Maastricht University Medical Center in the ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vasc ...

Riociguat is generally safe and effective for PAH patients with coexisting cardiac and metabolic conditions, a trials ...

PFT is crucial for diagnosing and managing respiratory conditions such as asthma, chronic obstructive pulmonary disease and ...